News
A federal appeals court on Thursday shut down AstraZeneca’s challenge to the U.S. government’s program that gives the ...
By Alistair Smout, Andrew MacAskill and Andrea Shalal LONDON/WASHINGTON (Reuters) -U.S. President Donald Trump and British ...
Two new RCTs of rituximab will soon begin in the United Kingdom: A biomarker-based trial with add-on belimumab and another in ...
13h
Clinical Trials Arena on MSNAstraZeneca and Daiichi’s Enhertu shows pCR rate improvement in breast cancer trialAstraZeneca and Daiichi's Enhertu, followed by THP, has shown pCR rate improvement in the randomised DESTINY-Breast11 Phase ...
Mikko Rantanen had his second hat trick in as many games Wednesday, lifting the Dallas Stars to a 3-2 win against the ...
Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...
The AstraZeneca share price has pulled back in recent months. Dr James Fox explores how the stock compares with pharma peer GSK. The post Does the GSK or AstraZeneca share price currently offer the ...
10h
India Today on MSNIndia expands use of AstraZeneca's drug for advanced breast cancer casesThe medicine, Trastuzumab deruxtecan, was already available for some breast and stomach cancers. It has been approved to ...
1h
HealthDay on MSNAsthma Attacks Increase for Some Women Taking Progestogen-Only PillUse of a combined oral contraceptive (COC) is not associated with asthma in women of reproductive age, but use of a ...
7h
GlobalData on MSNPatient centricity and effective designs drive clinical trial successA panel at OCT Europe touched upon where the European clinical trial industry is headed and the impact of technology and ...
2hon MSN
Aston Martin rose 13.9% after the levy on UK vehicles was cut to 10% from 27.5%. But that is still well above the 2.5% before ...
Regardless of the macroeconomic environment, we remain focused on applying our well-established, long-term, bottom-up EQV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results